These studies suggest that the inhibition of HIF-1α in myeloid cells represents a potential therapeutic strategy for treating sepsis-induced ALI, but the role of leukocyte-specific HIF-2α in inflammatory lung injury is yet to be fully elucidated. The gene discussed is HIF1A; the disease is acute respiratory distress syndrome.